Glo is an AI‑driven text companion that helps adults on GLP‑1 therapy stay adherent and manage daily health questions. It sends daily SMS check‑ins, creates weekly personalized plans based on the user’s symptoms, goals, nutrition and exercise, and answers side‑effect or dosing queries using a clinically‑informed knowledge base.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals using GLP‑1 medications often struggle to maintain consistent habits, track side effects, and access reliable, personalized guidance, leading to suboptimal outcomes and increased frustration.
Solution
Glo is an AI‑driven text companion that engages users throughout their GLP‑1 therapy. It sends daily check‑ins via SMS to monitor status and encourage adherence without judgment. Each week, Glo generates a personalized plan that aligns with the user’s symptoms, goals, nutrition, and exercise preferences. Users can ask on‑demand questions about side effects, dosing, or lifestyle, receiving answers grounded in clinical research. All interactions, progress data, and recommendations are stored within a single text thread, eliminating the need for separate logging tools.
Target Audience
Glo is aimed at adults prescribed GLP‑1 therapies who seek continuous, personalized support to improve adherence and manage daily health questions.
Features
- Automated daily SMS check‑ins that capture user feedback and prompt adherence
- Weekly, AI‑crafted plans tailored to individual goals, symptoms, and lifestyle factors
- Clinically‑informed knowledge base delivering evidence‑based answers to medication‑related queries
- Conversational progress tracking consolidated in one text thread for easy reference
- Support for nutrition, exercise, and side‑effect management guidance